Home Bromides 1027511-41-6
1027511-41-6,MFCD10574908
Catalog No.:AA00087Q

1027511-41-6 | Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$16.00   $11.00
- +
250mg
95%
in stock  
$19.00   $14.00
- +
500mg
95%
in stock  
$30.00   $21.00
- +
1g
95%
in stock  
$51.00   $36.00
- +
2g
95%
in stock  
$100.00   $70.00
- +
5g
95%
in stock  
$184.00   $129.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00087Q
Chemical Name:
Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
CAS Number:
1027511-41-6
Molecular Formula:
C9H8BrN3O2
Molecular Weight:
270.0827
MDL Number:
MFCD10574908
SMILES:
CCOC(=O)c1cnn2c1ncc(c2)Br
Properties
Computed Properties
 
Complexity:
252  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Rotatable Bond Count:
3  
XLogP3:
1.2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/234345,2018,A1Locationinpatent:Page/Pagecolumn219

[2]Abdukirim,Elyar;Cheng,Kai-Wen;Chou,Tsui-Fen;Huo,Ran;Kang,Guifeng;Li,Shan;Wang,Feng;Zhang,Gang;Zhu,Yingying[BioorganicandMedicinalChemistry,2022,vol.62]

[3]Abdukirim,Elyar;Cheng,Kai-Wen;Chou,Tsui-Fen;Huo,Ran;Kang,Guifeng;Li,Shan;Wang,Feng;Zhang,Gang;Zhu,Yingying[BioorganicandMedicinalChemistry,2022,vol.62]

[4]CurrentPatentAssignee:KANCERAAB-WO2008/116898,2008,A1Locationinpatent:Page/Pagecolumn97-98

[5]Robb,GraemeR.;Boyd,Scott;Davies,ChristopherD.;Dossetter,AlexanderG.;Goldberg,FrederickW.;Kemmitt,PaulD.;Scott,JamesS.;Swales,JohnG.[MedChemComm,2015,vol.6,#5,p.926-934]

[1]CurrentPatentAssignee:KANCERAAB-WO2008/116898,2008,A1Locationinpatent:Page/Pagecolumn97

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/108723,2017,A2Locationinpatent:Page/Pagecolumn342

[3]Bryan,MarianC.;Drobnick,Joy;Gobbi,Alberto;Kolesnikov,Aleksandr;Chen,Yongsheng;Rajapaksa,Naomi;Ndubaku,Chudi;Feng,Jianwen;Chang,Willy;Francis,Ross;Yu,Christine;Choo,EdnaF.;Dement,Kevin;Ran,Yingqing;An,Le;Emson,Claire;Huang,Zhiyu;Sujatha-Bhaskar,Swathi;Brightbill,Hans;Dipasquale,Antonio;Maher,Jonathan;Wai,John;McKenzie,BrentS.;Lupardus,PatrickJ.;Zarrin,AliA.;Kiefer,JamesR.[JournalofMedicinalChemistry,2019,vol.62,#13,p.6223-6240]

[4]Abdukirim,Elyar;Cheng,Kai-Wen;Chou,Tsui-Fen;Huo,Ran;Kang,Guifeng;Li,Shan;Wang,Feng;Zhang,Gang;Zhu,Yingying[BioorganicandMedicinalChemistry,2022,vol.62]

[5]Abdukirim,Elyar;Cheng,Kai-Wen;Chou,Tsui-Fen;Huo,Ran;Kang,Guifeng;Li,Shan;Wang,Feng;Zhang,Gang;Zhu,Yingying[BioorganicandMedicinalChemistry,2022,vol.62]

[6]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2017/101411,2017,A1Locationinpatent:Paragraph0425;0426;0427;0428

[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/158634,2021,A1Locationinpatent:Paragraph00790-00791

[2]Robb,GraemeR.;Boyd,Scott;Davies,ChristopherD.;Dossetter,AlexanderG.;Goldberg,FrederickW.;Kemmitt,PaulD.;Scott,JamesS.;Swales,JohnG.[MedChemComm,2015,vol.6,#5,p.926-934]

[1]Robb,GraemeR.;Boyd,Scott;Davies,ChristopherD.;Dossetter,AlexanderG.;Goldberg,FrederickW.;Kemmitt,PaulD.;Scott,JamesS.;Swales,JohnG.[MedChemComm,2015,vol.6,#5,p.926-934]

[2]CurrentPatentAssignee:KANCERAAB-WO2008/116898,2008,A1

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/234345,2018,A1

1027511-41-6   
3-(5-hydroxy-2-adamantyl)carbamoylpyrazolo1,5-apyrimidin-6-ylboronicacid 

[1]Robb,GraemeR.;Boyd,Scott;Davies,ChristopherD.;Dossetter,AlexanderG.;Goldberg,FrederickW.;Kemmitt,PaulD.;Scott,JamesS.;Swales,JohnG.[MedChemComm,2015,vol.6,#5,p.926-934]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1027511-41-6 Molecular Formula|1027511-41-6 MDL|1027511-41-6 SMILES|1027511-41-6 Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate